Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/23/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/23/25 | 3 | Initial statement of beneficial ownership of securities |
|
5 | |
| 12/23/25 | SCHEDULE 13G | Statement of Beneficial Ownership by Certain Investors |
|
4 | |
| 12/16/25 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/16/25 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/16/25 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/16/25 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/16/25 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/16/25 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/16/25 | EFFECT | Notice of Effectiveness |
|
1 |
